Association of transforming growth factor-β1 T869C gene polymorphism with diabetic nephropathy risk

Nephrology

Volumn 19, Issue 2, 2014, Pages 107-115

  Zhou, Tian Biao ^a   Jiang, Zong Pei ^a   Qin, Yuan Han ^b   Drummen, Gregor P C ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c Cellular Stress and Ageing Program   (Germany)

Author keywords

diabetic nephropathy; gene polymorphism; meta analysis; T869C; transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

AFRICA; ALLELE; ARTICLE; ASIAN; CAUCASIAN; DIABETIC NEPHROPATHY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT;

DIABETIC NEPHROPATHY; GENE POLYMORPHISM; META-ANALYSIS; T869C; TRANSFORMING GROWTH FACTOR-Β1;

DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RISK; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84892539351     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12176     Document Type: Article

References (34)

1. Hou YL, Chen H, Dong ZH, et al. Clinical significance of serum transforming growth factor-beta1 in lung cancer. Cancer Epidemiol. 2013; 37: 750-753.
2. Gonzalez-Ramos M, de Frutos S, Griera M, et al. Integrin-linked kinase mediates the hydrogen peroxide-dependent transforming growth factor-beta1 up-regulation. Free Radic. Biol. Med. 2013; 61C: 416-427.
3. Kong LL, Wu H, Cui WP, et al. Advances in murine models of diabetic nephropathy. J. Diabetes Res. 2013; 2013: 797548.
4. Park JT, Kato M, Yuan H, et al. FOG2 down-regulation by TGF-beta1-induced microRNA-200b/c leads to Akt kinase activation and Glomerular Mesangial Hypertrophy Related to Diabetic Nephropathy. J. Biol. Chem. 2013; 288: 22469-22480.
5. Deshpande SD, Putta S, Wang M, et al. Transforming growth factor-beta induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy. Diabetes 2013; 62: 3151-3162.
6. Gu L, Gao Q, Ni L, Wang M, Shen F,. Fasudil inhibits epithelial- myofibroblast transdifferentiation of human renal tubular epithelial HK-2 cells induced by high glucose. Chem. Pharm. Bull (Tokyo) 2013; 61: 688-694.
7. Kato M, Dang V, Wang M, et al. TGF-beta induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy. Sci. Signal. 2013; 6: ra43.
8. Verhave JC, Bouchard J, Goupil R, et al. Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: A prospective study. Diabetes Res. Clin. Pract. 2013; doi: 10.1016/j.diabres.2013.07.006
9. Zhou TB, Yin SS,. Association of matrix metalloproteinase-9 level with the risk of renal involvement for Henoch-Schonlein purpura in children. Ren. Fail. 2013; 35: 425-429.
10. Zhou TB, Yin SS, Liang R,. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients. J. Renin Angiotensin Aldosterone Syst. 2013; 14: 235-241.
11. Cheng HY, You HY, Zhou TB,. Relationship between GSTM1/GSTT1 null genotypes and renal cell carcinoma risk: A meta-analysis. Ren. Fail. 2012; 34: 1052-1057.
12. Zhou TB, Qin YH, Xu HL,. Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: A meta-analysis of experimental and human studies. Mol. Biol. Rep. 2012; 39: 9347-9354.
13. Zhou TB, Yin SS,. Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease. Ren. Fail. 2013; 35: 573-578.
14. Zhou TB, Yin SS, Jiang ZP,. Association of angiotensin II type-1 receptor A1166C gene polymorphism with the susceptibility of end-stage renal disease. J. Recept. Signal Transduct. Res. 2013; 33: 325-331.
15. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
16. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
17. Wong TY, Poon P, Chow KM, et al. Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese. Kidney Int. 2003; 63: 1831-1835.
18. Ng DP, Warram JH, Krolewski AS,. TGF-beta 1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: An investigation of multiple known DNA sequence variants. Am. J. Kidney Dis. 2003; 41: 22-28.
19. Wei Y, Lan Y, You Y, et al. The serum level and the genotype of TGF-β1 in patients with type 2 diabetic nephropathy. Chin. J. Lab. Med. 2005; 28: 173-177.
20. McKnight AJ, Savage DA, Patterson CC, Sadlier D, Maxwell AP,. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy. BMC Med. Genet. 2007; 8: 5.
21. Buraczynska M, Baranowicz-Gaszczyk I, Borowicz E, Ksiazek A,. TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes. Nephron Physiol. 2007; 106: p69-75.
22. Wei M, Lu Y, Li S, She Y,. Study of relationship between TGF-β Leu 10 Prolymorphism and diabetic nephropathy in type 2 diabetes. Chin. J. Diabetes 2008; 16: 538-540.
23. Ahluwalia TS, Khullar M, Ahuja M, et al. Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians. PLoS ONE 2009; 4: e5168.
24. Jahromi MM, Millward BA, Demaine AG,. Significant correlation between association of polymorphism in codon 10 of transforming growth factor-beta1 T (29) C with type 1 diabetes and patients with nephropathy disorder. J. Interferon Cytokine Res. 2010; 30: 59-66.
25. Valladares-Salgado A, Angeles-Martinez J, Rosas M, et al. Association of polymorphisms within the transforming growth factor-beta1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations. Nephrology (Carlton) 2010; 15: 644-648.
26. Chen J, Li X, Wei J, Deng Y, Li K, Tang L,. Association of the TGF-β1 gene promoter -869C/T polymorphisms with diabetic nephropathy in type 2 diabetes. J. Pract. Med. 2010; 26: 4087-4089.
27. Chai W, Liu H, Yan S,. Association of transforming growth factor-β1 gene polymorphism with diabetic nephropathy susceptibility. China Mod. Med. 2009; 16: 33-34.
28. Pan S, Han X, Yang L, Lin J, Chen X,. Association of a 29T→C polymorphism of the TGF-β1 gene with genetic susceptibility to type 2 diabetic nephropathy. Chin. J. Diabetes 2007; 15: 416-417.
29. Rao W, Jian X, Zhou W,. The relationship between transforming growth factor-β1 gene polymorphism and diabetic nephropathy risk in Guangdong Han population. Int. Med. Health Guid. News 2011; 17: 654-656.
30. El-Sherbini SM, Shahen SM, Mosaad YM, Abdelgawad MS, Talaat RM,. Gene polymorphism of transforming growth factor-beta1 in Egyptian patients with type 2 diabetes and diabetic nephropathy. Acta Biochim. Biophys. Sin. (Shanghai) 2013; 45: 330-338.
31. Mou X, Liu WH, Zhou DY, et al. Association of Chinese medicine constitution susceptibility to diabetic nephropathy and transforming growth factor-beta1 (T869C) gene polymorphism. Chin. J. Integr. Med. 2011; 17: 680-684.
32. Jia H, Yu L, Gao B, Ji Q,. Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: A meta-analysis. Endocrine 2011; 40: 372-378.
33. Wang H, Li P, Feng ZC,. Meta-analysis demonstrates association of the TGF-beta1 gene -C509T polymorphism with susceptibility to IgA nephropathy in European but not in Asian populations. Genet. Mol. Res. 2013; 12: 434-442.
34. Thakkinstian A, Dmitrienko S, Gerbase-Delima M, et al. Association between cytokine gene polymorphisms and outcomes in renal transplantation: A meta-analysis of individual patient data. Nephrol. Dial. Transplant. 2008; 23: 3017-3023.